The albumin to globulin ratio (AGR) is used as a prognostic marker in acute ischemic cardiovascular events. We investigated whether serum AGR, fibrinogen, and fibrinogen to albumin ratio (FAR) are related to the presence and severity of coronary artery disease (CAD). Patients who underwent coronary angiography procedures were analyzed retrospectively. The severity of CAD was assessed by the Gensini score. The study population (3031 patients; 1071 females and 1960 males) was divided into 3 tertiles based on AGR values. Gensini score, lipid levels, diabetes mellitus (DM), hypertension (HT), age, and fibrinogen level were higher in the low AGR group. Pearson correlation analysis showed that AGR (r = −0.068, P < .001) was negatively and fibrinogen (r = 0.187, P < .001) was positively correlated with the Gensini score. Male gender, HT, smoking, DM, age, high triglyceride (TG) level, low-density lipoprotein cholesterol (LDL-C) >160 mg/dL, estimated glomerular filtration rate (eGFR) <60 mL/min, and fibrinogen level >3.5 g/L were independent predictors of CAD. Male gender, age, eGFR, DM, LDL-C, TG, and FAR had an independent positive relation to the Gensini score. In conclusion, similar to traditional risk factors, plasma fibrinogen and albumin levels showed a close relation with the presence and severity of CAD.
RossRGlomsetJA. Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science. 1973;180:1332–9.
2.
SorescuGPSykesMWeissD, et al.Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response. J Biol Chem. 2003;278:31128–35.
3.
SimsFHGavinJBEdgarSKoelmeyerT. Diffusion of gamma globulin into the arterial wall identifies localized entry of lipid and cells in atherosclerosis. Coron Artery Dis. 2001;12:21–30.
4.
OettlKStauberRE. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol. 2007;151:580–90.
5.
GabayCKushnerI. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med Overseas Ed. 1999;340:448–54.
6.
NelsonJJLiaoDSharrettAR, et al.Serum albumin level as a predictor of incident coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol. 2000;15:468–77.
7.
DaneshJCollinsRApplebyPPetoR. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998;279:1477–82.
8.
WeijenbergMPFeskensEJSouverijnJHKromhoutD. Serum albumin, coronary heart disease risk, and mortality in an elderly cohort. Epidemiology. 1997;8:87–92.
9.
DjousséLRothmanKJCupplesLALevyDEllisonRC. Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham offspring study. Circulation. 2002;106:2919–24.
10.
LiuMChanCPYanBP, et al.Albumin levels predict survival in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2012;14:39–44.
11.
SuWAnTZhouQ, et al.Serum albumin is a useful prognostic indicator and adds important information to NT-proBNP in a Chinese cohort of heart failure. Clin Biochem. 2012;45:561–5.
12.
LiuLMurrayDKDameronCT, et al.Biochemical characterization of procoagulant albumin. Thromb Res. 1997;85:399–411.
13.
DintenfassLLakeB. Blood viscosity factors in evaluation of submaximal work output and cardiac activity in men. Angiology. 1977;28:788–98.
14.
PaarMRossmannCNussholdC, et al.Anticoagulant action of low, physiologic, and high albumin levels in whole blood. PLoS One. 2017;12:e0182997.
15.
MikhailidisDPBarradasMAMarisA, et al.Fibrinogen mediated activation of platelet aggregation and thromboxane A2 release: pathological implications in vascular disease. J Clin Pathol. 1985;38:1166–71.
16.
BasMKirchhartzNHochfeldJ, et al.Potential role of vasomotor effects of fibrinogen in bradykinin-induced angioedema. J Allergy Clin Immunol. 2008;121:969–75.
17.
LeveyASBoschJPLewisJB, et al.A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–70.
18.
GensiniGG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51:606.
19.
RossR. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340:115–26.
20.
LibbyP. Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol. 2003;91:3–6.
21.
LibbyP. Molecular basis of the acute coronary syndromes. Circulation. 1995;91:2844–2850.
22.
MarchioPGuerra-OjedaSVilaJM, et al.Targeting early atherosclerosis: a focus on oxidative stress and inflammation. Oxid Med Cell Longev. 2019;2019:8563845.
23.
GeorgesJLRupprechtHJBlankenbergS, et al.Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am J Cardiol. 2003;92:515–21.
24.
GillumRFMakucDM. Serum albumin, coronary heart disease, and death. Am Heart J. 1992;123:507–13.
25.
CortiMCSaliveMEGuralnikJM. Serum albumin and physical function as predictors of coronary heart disease mortality and incidence in older persons. J Clin Epidemiol. 1996;49:519–26.
26.
CortiMCGuralnikJMSaliveMESorkinJD. Serum albumin level and physical disability as predictors of mortality in older persons. JAMA. 1994;272:1036–42.
27.
PhillipsAShaperAGWhincupPH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet. 1989;2:1434–6.
28.
GanotakisESVrentzosGEGaziIF, et al.Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equation. In Vivo. 2007;21:685–94.
29.
McPhersonR. ‘‘Chapter 19: Specific Proteins’’ Mc Phersonand Pincus: Henry’s Clinical Diagnosis and Management by laboratory Methods, 21st ed; 2006:262–270.
30.
AndersonJLCarlquistJFMuhlesteinJB, et al.Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol. 1998;32:35–41.
31.
LucGBardJMJuhan-VagueI, et al.C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME study. Arterioscler Thromb Vasc Biol. 2003;23:1255–61.
32.
SmithEB. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis. Clin Hematol. 1986;2:355–70.
33.
DuerMJFriscicTProudfootD, et al.Mineral surface in calcified plaque is like that of bone. Arterioscler Thromb Vasc Biol. 2008;28:2030–4.
34.
ParkSParkSLeeSH, et al.Pre treatment albumin-to-globulin ratio as a predictive marker for tyrosine kinase inhibitor in non-small cell lung cancer. Cancer Biomark. 2016;16:425–33.
35.
OkiSToiyamaYOkugawaY, et al.Clinical burden of preoperative albumin-globulin ratio in esophageal cancer patient. Am J Surg. 2017;214:891–8.
36.
SuhBParkSShinDW, et al.Low albumin-to-globulin ratio associated with cancer incidence and mortality in generally healthy adults. Ann Oncol. 2014;25:2260–6.
37.
AzabBBibawyJHarrisK, et al.Value of albumin-globulin ratio as a predictor of all-cause mortality after non-ST elevation myocardial infarction. Angiology. 2013;64:137–45.
38.
BeamerNCoullBMSextonG, et al.Fibrinogen and the albumin–globulin ratio in recurrent stroke. Stroke. 1993;24:1133–9.
39.
ChaudharyRSukhiAChaudharyR, et al.Gender differences in thrombogenicity among patients with angina and non-obstructive coronary artery disease. J Thromb Thrombolysis. 2019;48:373–81.
40.
AmbroseJABaruaRS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43:1731–7.
41.
El-ZayadiAR. Heavy smoking and liver. World J Gastroenterol. 2006;12:6098–101.
42.
SinhaSLubenRNWelchA, et al.Fibrinogen and cigarette smoking in men and women in the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population. Eur J Cardiovasc Prev Rehabil. 2005;12:144–50.
43.
LevittDGLevittMD. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med. 2016;9:229–55.
44.
De MaatMP. Effects of diet, drugs, and genes on plasma fibrinogen levels. Ann N Y Acad Sci. 2001;936:509–21.
45.
DollRPetoRBorehamJ, et al.Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ. 2004;328:1519.
46.
LuYHajifathalianKRimmEB, et al.Mediators of the effect of body mass index on coronary heart disease: decomposing direct and indirect effects. Epidemiology. 2015;26:153–62.
47.
VanninenELaitinenJUusitupaM. Physical activity and fibrinogen concentration in newly diagnosed NIDDM. Diabetes Care. 1994;17:1031–8.
48.
MiuraKNakagawaHUeshimaH, et al.Dietary factors related to higher plasma fibrinogen levels of Japanese-Americans in Hawaii compared with Japanese in Japan. Arterioscler Thromb Vasc Biol. 2006;26:1674–9.
